Montu is on a mission to improve the lives of millions of Australians through medical cannabis therapies. As an early investor, I have seen firsthand how the company has helped thousands of patients.
Montu has built an integrated cannabis ecosystem, which streamlines the journey for patients end-to-end, and sets new standards in cannabis care. Montu has grown by 20,728% over the three years to 2022. This month, Montu was named by Deloitte as the country’s fastest-growing technology company and by the Australian Financial Review (AFR) as the fifth fastest-growing start-up.
The Deloitte Technology Fast 50 ranks the 50 fastest-growing public and private technology companies in the country based on minimum cumulative revenues of A$8 million over three years. Montu took out first place, growing by a massive 20,728% over the three years to 2022 – the fastest growth of any tech company that has made the list since 2004.
Cannabis is the fastest growing industry in the world, resulting in a US$150bn global market over the forthcoming years. Changing cannabis legislation in Australia and New Zealand opens a new chapter in healthcare with access to safer and healthier medication, and ultimately the road to a wellness and recreational market.
Montu connects Australians to highly qualified doctors via our Alternaleaf telehealth platform. And support them throughout their journey, with our dedicated patient care team. From online booking, to tele-consultations, product selection and dispensing of medication. Montu provide patients with a supportive and judgement-free environment.
Montu has built an integrated cannabis ecosystem, which streamlines the journey for patients end-to-end, and sets new standards in cannabis care. After decades of scientific negligence of the cannabis plant, research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives. Australia and New Zealand are predicted to be the next major cannabis markets, estimated to grow to AU$1.7 billion by 2023.